Posts tagged: bayer
Health Alliance, Bayer sign outcomes-based contract to support MS patients
Bayer HealthCare and Health Alliance Medical Plans have entered into an outcomes-based contract for people with relapsing-remitting multiple sclerosis (MS) who are taking Betaseron (interferon beta-1b) to reduce the frequency of clinical exacerbations.
Bayer and J&J’s blood thinner drug triumphs at late phase clinical trial
Drug makers Bayer AG and Johnson & Johnson’s new blood clot preventing drug can provide life-saving benefits at very low doses in patients who suffer from acute coronary syndrome finds a new clinical trial.
Bayer drug unproven as stroke preventer: US
US regulators said Tuesday that Xarelto, a Bayer-made drug approved in July for preventing blood clots, is so far unproven for a new proposed use as a stroke preventer.
Bayer Healthcare to provide over 600,000 moxifloxacin tablets to fight MDR-TB in China
Bayer Healthcare announced on Monday it "has agreed to support the World Health Organization (WHO) and the Stop TB Partnership in the fight against multidrug-resistant tuberculosis (MDR-TB) by making 620,000 tablets of the antibiotic moxifloxacin available to WHO," according to a Bayer press release.
The only European researcher to win this year’s Early Career Bayer Hemophilia Award is Portuguese
Vanessa Oliveira, researcher at the Instituto de Medicina Molecular in Portugal won a prestigious and competitive Early Career Bayer Hemophilia Award. Oliveira will develop a strategy to reprogramme the immune system of hemophilia patients to avoid immune targeting of the most used clotting therapeutics. Oliveira was the only European ...
The only European researcher to win this year’s Early Career Bayer Hemophilia Award is Portuguese
(Instituto de Medicina Molecular) Vanessa Oliveira, researcher at the Instituto de Medicina Molecular in Portugal won a prestigious and competitive Early Career Bayer Hemophilia Award. Oliveira will develop a strategy to reprogramme the immune system of hemophilia patients to avoid immune targeting of the most used clotting therapeutics. Oliveira ...
Bayer Yakuhin seeks marketing authorization in Japan for EYLEA for treatment of wet AMD
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer Yakuhin, Ltd., Osaka, Japan, has submitted an application to the Ministry of Health, Labor and Welfare (MHLW) in Japan for marketing authorization for EYLEA, also known as VEGF Trap-Eye, for the treatment of the neovascular form of age-related macular degeneration ...
Bayer flags strong results of prostate cancer drug
German chemical and pharmaceutical group Bayer said Monday that its Alpharadin treatment for prostate cancer has shown positive results in advanced trials.
Bayer unveils a faster-acting aspirin
Bayer AG is looking for a speedy remedy for stagnant aspirin sales. The company is introducing a reformulated aspirin today that works in half the time of its regular aspirin.
Medtronic And Bayer Healthcare Expand International Alliance
Medtronic, Inc. (NYSE: MDT) and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients worldwide. Since 2007, the two companies have successfully collaborated internationally in over 20 countries by providing Bayer's ...
Medtronic, Bayer HealthCare expand global alliance to develop next generation diabetes management solutions
Medtronic, Inc. and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients, state-of-the-art, wireless blood glucose meters worldwide.